Evidence map›Paper›PMID 39060621›Full record

ArticleScientific reports2024

Neurobiological modulation with REAC technology: enhancing pain, depression, anxiety, stress, and quality of life in post-polio syndrome subjects.

Jeyce Adrielly André Nogueira, Acary Souza Bulle Oliveira, Monalisa Pereira Motta, Alcione Aparecida Vieira de Souza Moscardi, Vanessa Manchim Favaro, Claudete Munhoz Teixeira, Amanda Orasmo Simcsik, Maria Clara Patrizi, Maria Salete Conde, Arianna Rinaldi and 2 more

Abstract read

PubMed Full text at PMC Publisher

In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it

0cells of the map it votes in

9citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jeyce Adrielly André NogueiraDivision of Neuromuscular Diseases, Department of Neurology and Neurosurgery, Federal University of São Paulo, São Paulo, 01000-000, Brazil.

Acary Souza Bulle OliveiraDivision of Neuromuscular Diseases, Department of Neurology and Neurosurgery, Federal University of São Paulo, São Paulo, 01000-000, Brazil. acary.bulle@unifesp.br.

Monalisa Pereira MottaDivision of Neuromuscular Diseases, Department of Neurology and Neurosurgery, Federal University of São Paulo, São Paulo, 01000-000, Brazil.

Alcione Aparecida Vieira de Souza MoscardiDepartment of Preventive Medicine, Federal University of São Paulo, São Paulo, 01000-000, Brazil.

Vanessa Manchim FavaroDivision of Neuromuscular Diseases, Department of Neurology and Neurosurgery, Federal University of São Paulo, São Paulo, 01000-000, Brazil.

Claudete Munhoz TeixeiraDivision of Neuromuscular Diseases, Department of Neurology and Neurosurgery, Federal University of São Paulo, São Paulo, 01000-000, Brazil.

Amanda Orasmo SimcsikDivision of Neuromuscular Diseases, Department of Neurology and Neurosurgery, Federal University of São Paulo, São Paulo, 01000-000, Brazil.

Maria Clara PatriziDivision of Neuromuscular Diseases, Department of Neurology and Neurosurgery, Federal University of São Paulo, São Paulo, 01000-000, Brazil.

Maria Salete CondeDivision of Neuromuscular Diseases, Department of Neurology and Neurosurgery, Federal University of São Paulo, São Paulo, 01000-000, Brazil.

Arianna RinaldiDepartment of Adaptive Neuro Psycho Physio Pathology and Neuro Psycho Physical Optimization, Rinaldi Fontani Institute, 50144, Florence, Italy.

Vania FontaniDepartment of Adaptive Neuro Psycho Physio Pathology and Neuro Psycho Physical Optimization, Rinaldi Fontani Institute, 50144, Florence, Italy.

Salvatore RinaldiDepartment of Adaptive Neuro Psycho Physio Pathology and Neuro Psycho Physical Optimization, Rinaldi Fontani Institute, 50144, Florence, Italy. srinaldi@irf.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Post-polio syndrome (PPS) brings new challenges for polio survivors, including muscle decline, pain, depression, and diminished quality of life. This study explored the potential of REAC neuromodulatory treatments to ease pain, improve mood, and enhance quality of life in PPS patients. 17 individuals with PPS (average age 54.8) received three REAC treatments: Neuro Postural Optimization, Neuro Psycho Physical Optimization, and Neuro Psycho Physical Optimization-Cervico Brachial. Pain, depression, anxiety, stress, and quality of life were assessed before and after using established scales. REAC treatments significantly reduced pain across various dimensions, along with depression, anxiety, and stress levels. Additionally, patients reported improved physical and psychological quality of life. This study suggests REAC neuromodulatory treatments as a promising non-invasive option to improve pain, emotional well-being, and quality of life in individuals with PPS.

Indexed as

AnxietyDepressionPostpoliomyelitis SyndromeQuality of LifeStress, PsychologicalAdultAgedEye Movement Desensitization ReprocessingFemaleHumansMaleMiddle AgedPainPain ManagementAnxietyDepressionPainPost-polio syndromeQuality of lifeREAC technologyStress

Identifiers

PMID39060621

DOI10.1038/s41598-024-68200-5

PMCPMC11282290

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.